Korea Particle Therapy Cancer Center Co., Ltd signed a share contract to acquire 31.6% in HS Vital Co., Ltd. (KOSDAQ:A204990) from Jiyoon Shin for KRW 20 billion on September 2, 2019. Korea Particle Therapy Cancer Center Co., Ltd will acquire 10 million shares at KRW 2000 per share. Post completion, Korea Particle Therapy Cancer Center Co., Ltd will be the largest shareholder of HS Vital Co., Ltd. and Jiyoon Shin will hold 19.5% stake. The consideration will be funded from internal funds. As on September 2, 2019, the deal is partially completed as Korea Particle Therapy Cancer Center Co., Ltd acquired 30.89% representing 9.8 million shares in HS Vital Co., Ltd. The deal is expected to close on September 2, 2019.